 New York, New York--Newsfile Corp. - April 16, 2021 - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Immunovant, Inc. Immunovant or the Company NASDAQ: IMVT from October 2, 2019 through February 1, 2021 the Class Period. The lawsuit filed in... 